Waiczies S - Search Results

1

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis.

Millward JM, Ramos Delgado P, Smorodchenko A, Boehmert L, Periquito J, Reimann HM, Prinz C, Els A, Scheel M, Bellmann-Strobl J, Waiczies H, Wuerfel J, Infante-Duarte C, Chien C, Kuchling J, Pohlmann A, Zipp F, Paul F, Niendorf T, Waiczies S. Millward JM, et al. Among authors: waiczies h, waiczies s. JCI Insight. 2020 Nov 5;5(21):e140040. doi: 10.1172/jci.insight.140040. JCI Insight. 2020. PMID: 33148886 Free PMC article.

2

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.

Dörr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F. Dörr J, et al. Among authors: waiczies s. J Neurosci. 2002 Feb 15;22(4):RC209. doi: 10.1523/JNEUROSCI.22-04-j0001.2002. J Neurosci. 2002. PMID: 11844843 Free PMC article.

3

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells.

Lünemann JD, Waiczies S, Ehrlich S, Wendling U, Seeger B, Kamradt T, Zipp F. Lünemann JD, et al. Among authors: waiczies s. J Immunol. 2002 May 15;168(10):4881-8. doi: 10.4049/jimmunol.168.10.4881. J Immunol. 2002. PMID: 11994437

4

Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis.

Waiczies S, Weber A, Lünemann JD, Aktas O, Zschenderlein R, Zipp F. Waiczies S, et al. J Neuroimmunol. 2002 May;126(1-2):213-20. doi: 10.1016/s0165-5728(02)00067-x. J Neuroimmunol. 2002. PMID: 12020973

5

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.

Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F. Aktas O, et al. Among authors: waiczies s. J Exp Med. 2003 Mar 17;197(6):725-33. doi: 10.1084/jem.20021425. Epub 2003 Mar 10. J Exp Med. 2003. PMID: 12629065 Free PMC article.

6

Atorvastatin induces T cell anergy via phosphorylation of ERK1.

Waiczies S, Prozorovski T, Infante-Duarte C, Hahner A, Aktas O, Ullrich O, Zipp F. Waiczies S, et al. J Immunol. 2005 May 1;174(9):5630-5. doi: 10.4049/jimmunol.174.9.5630. J Immunol. 2005. PMID: 15843562

7

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.

Aktas O, Waiczies S, Zipp F. Aktas O, et al. Among authors: waiczies s. J Neuroimmunol. 2007 Mar;184(1-2):17-26. doi: 10.1016/j.jneuroim.2006.11.026. Epub 2007 Jan 10. J Neuroimmunol. 2007. PMID: 17222462 Review.

8

Impact of HMG-CoA reductase inhibition on brain pathology.

Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP. Zipp F, et al. Among authors: waiczies s. Trends Pharmacol Sci. 2007 Jul;28(7):342-9. doi: 10.1016/j.tips.2007.05.001. Epub 2007 Jun 15. Trends Pharmacol Sci. 2007. PMID: 17573124 Review.

9

Geranylgeranylation but not GTP loading determines rho migratory function in T cells.

Waiczies S, Bendix I, Prozorovski T, Ratner M, Nazarenko I, Pfueller CF, Brandt AU, Herz J, Brocke S, Ullrich O, Zipp F. Waiczies S, et al. J Immunol. 2007 Nov 1;179(9):6024-32. doi: 10.4049/jimmunol.179.9.6024. J Immunol. 2007. PMID: 17947676

10

New developments in understanding and treating neuroinflammation.

Infante-Duarte C, Waiczies S, Wuerfel J, Zipp F. Infante-Duarte C, et al. Among authors: waiczies s. J Mol Med (Berl). 2008 Sep;86(9):975-85. doi: 10.1007/s00109-007-0292-0. Epub 2008 Jan 15. J Mol Med (Berl). 2008. PMID: 18196212 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters